Immune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs
Open accessThe DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Abstract
Summary: Antiretroviral therapy (ART) is a life‐saving intervention in human immunodeficiency virus (HIV) infection. Immune restoration after ART dramatically reduces the incidence and severity of opportunistic diseases and death. On some occasions, immune restoration may be erratic, leading to acute inflammatory responses (known as immune reconstitution inflammatory syndrome) shortly after ART initiation, or incomplete, with residual inflammation despite chronic treatment, leading to non‐infectious morbidity and mortality. We propose that ART may not always restore the perfect balance of innate and adaptive immunity in strategic milieus, predisposing HIV‐infected persons to complications of acute or chronic inflammation. The best current strategy for fully successful immune restoration is early antiretroviral therapy, which can prevent acquired immunodeficiency syndrome (AIDS)‐associated events, restrict cell subset imbalances and dysfunction, while preserving structural integrity of lymphoid tissues. Future HIV research should capitalize on innovative techniques and move beyond the static study of T‐cell subsets in peripheral blood or isolated tissues. Improved targeted therapeutic strategies could stem from a better understanding of how HIV perturbs the environmental niches and the mobility and trafficking of cells that affect the dynamic cell‐to‐cell interactions and determine the outcome of innate and adaptive immune responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006) · Nature Medicine · doi:10.1038/nm1511 · Cited by 3,559
A human memory T cell subset with stem cell–like properties
Gattinoni, L., Lugli, E., Ji, Y., Pos, Z., Paulos, C. M., Quigley, M. F., Almeida, J. R., Gostick, E., Yu, Z., Carpenito, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2446 · Cited by 1,974 · cited 1×
“Finally, it remains unclear how depletion and subsequent recovery with ART of T-memory stem cells, a recently described T-cell subset with robust proliferative and functional potential (99), may be affecting T-cell restoration in HIV.”
BackgroundAutran, B., Carcelain, G., Li, T. S., Blanc, C., Mathez, D., Tubiana, R., Katlama, C., Debré, P., & Leibowitch, J. (1997) · Science · doi:10.1126/science.277.5322.112 · Cited by 1,785 · cited 3×
“Initiating combination antiretroviral therapy (ART) can achieve suppression of viral replication and an increase in CD4 T-cell counts in the majority of patients (1), resulting in dramatic decreases in morbidity and AIDS-related mortality (2).”
Background. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050203 · Cited by 1,617
Guaraldi, G., Orlando, G., Zona, S., Menozzi, M., Carli, F., Garlassi, E., Berti, A., Rossi, E., Roverato, A., & Palella, F. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir627 · Cited by 1,331 · cited 2×
“Strikingly, even those with recovery of near-normal CD4 T-cell counts may maintain chronic immune activation that has been linked to an increased risk of non-AIDS-related morbidity and mortality (7, 8), making it clear that the detrimental effects of HIV infection go beyond CD4 T-cell depletion and immunodeficiency.”
BackgroundMehandru, S., Poles, M. A., Tenner-Racz, K., Horowitz, A., Hurley, A., Hogan, C., Boden, D., Racz, P., & Markowitz, M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041196 · Cited by 1,146 · cited 1×
“Although treatment with ART can produce a remarkable restoration of peripheral CD4 T cells, reduce CD4 T-cell activation, and improve CD4 T-cell populations at effector sites (51), some reports showed that restoration of CD4 T cells in the lamina propria may be incomplete, even after up to 5 years on ART (83).”
BackgroundMethotrexate and mortality in patients with rheumatoid arthritis: a prospective study
Choi, H. K., Hernán, M. A., Seeger, J. D., Robins, J. M., & Wolfe, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08213-2 · Cited by 1,127 · cited 1×
“Other immunomodulating drugs, particularly those with anti-inflammatory activity including methotrexate, shown to reduce cardiovascular events in patients with rheumatoid arthritis (130), and statins (131) continue to be investigated, and as we have shown, studies should predominantly focus on targets related to innat…”
Sáez-Cirión, A., Bacchus, C., Hocqueloux, L., Avettand-Fenoel, V., Girault, I., Lecuroux, C., Potard, V., Versmisse, P., Melard, A., Prazuck, T., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003211 · Cited by 1,011 · cited 1×
“A recent publication described 14 patients from the Virological and Immunological Studies in CONtrollers after Treatment Interruption (VISCONTI) cohort, who, after beginning therapy during acute HIV infection, went on to spontaneously control viral replication once treatment was interrupted (114).”
Greub, G., Ledergerber, B., Battegay, M., Grob, P., Perrin, L., Furrer, H., Burgisser, P., Erb, P., Boggian, K., Piffaretti, J.-C., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03232-3 · Cited by 894 · cited 1×
“Some of the risk factors for a limited CD4 T-cell recovery include older age (40), lower CD4 T-cell nadir prior to ART (41), and active co-infection, most notably with hepatitis C virus (42, 43), but the strongest predictor remains a lower nadir CD4 T-cell count before ART initiation.”
BackgroundMüller, M., Wandel, S., Colebunders, R., Attia, S., Furrer, H., & Egger, M. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70026-8 · Cited by 755 · cited 1×
“central nervous system versus lungs), and management (13).”
BackgroundHIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity.
Deeks, S. G., & Phillips, A. N. (2009) · BMJ · doi:10.1136/bmj.a3172 · Cited by 704 · cited 2×
“Strikingly, even those with recovery of near-normal CD4 T-cell counts may maintain chronic immune activation that has been linked to an increased risk of non-AIDS-related morbidity and mortality (7, 8), making it clear that the detrimental effects of HIV infection go beyond CD4 T-cell depletion and immunodeficiency.”
BackgroundPakker, N. G., Notermans, D. W., De Boer, R. J., Roos, M. T. L., Wolf, F. D., Hill, A., Leonard, J. M., Danner, S. A., Miedema, F., & Schellekens, P. T. A. (1998) · Nature Medicine · doi:10.1038/nm0298-208 · Cited by 701 · cited 1×
“With the initiation of ART, the accelerated differentiation of naive CD4 T cells into memory cells is slowed (1, 48), leading to replenishment of the naive subset (44) and a restoration of the CD4 TCR diversity (49).”
BackgroundHunt, P. W., Brenchley, J., Sinclair, E., McCune, J. M., Roland, M., Page‐Shafer, K., Hsue, P., Emu, B., Krone, M., Lampiris, H., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/524143 · Cited by 638 · cited 1×
“These persons also have elevated levels of inflammatory biomarkers, immune activation, and non-AIDS events, including atherosclerosis, in the absence of uncontrolled viremia or ART (72, 73), suggesting that the low (below detection by routine assays) HIV viremia may be playing a role in chronic inflammation in HIV.”
BackgroundShelburne, S. A., Visnegarwala, F., Darcourt, J., Graviss, E. A., Giordano, T. P., White, A. C., & Hamill, R. J. (2005) · AIDS · doi:10.1097/01.aids.0000161769.06158.8a · Cited by 632
Palmer, S., Wiegand, A. P., Maldarelli, F., Bazmi, H., Mican, J. M., Polis, M., Dewar, R. L., Planta, A., Liu, S., Metcalf, J. A., et al. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.10.4531-4536.2003 · Cited by 604 · cited 1×
“Ultra-sensitive assays detecting levels of viremia between 1 and 49 copies/ml have repeatedly shown that lower levels of HIV can still be identified in patients on ART (66, 67).”
BackgroundOldenhove, G., Bouladoux, N., Wohlfert, E. A., Hall, J. A., Chou, D., Dos santos, L., O'Brien, S., Blank, R., Lamb, E., Natarajan, S., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.10.001 · Cited by 575
T Cell Dynamics in HIV-1 Infection
Douek, D. C., Picker, L. J., & Koup, R. A. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141053 · Cited by 571
Favre, D., Mold, J., Hunt, P. W., Kanwar, B., Loke, P., Seu, L., Barbour, J. D., Lowe, M. M., Jayawardene, A., Aweeka, F., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000632 · Cited by 523 · cited 6×
“The role of Tregs should be further studied, and the trafficking of cells with accumulation in areas of antigen encounter should be better appreciated.”
BackgroundInfluentialInflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals
Duprez, D. A., Neuhaus, J., Kuller, L. H., Tracy, R., Belloso, W., De Wit, S., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044454 · Cited by 520
Experimental infection of bats with Geomyces destructans causes white-nose syndrome
Lorch, J. M., Meteyer, C. U., Behr, M. J., Boyles, J. G., Cryan, P. M., Hicks, A. C., Ballmann, A. E., Coleman, J. T. H., Redell, D. N., Reeder, D. M., et al. (2011) · Nature · doi:10.1038/nature10590 · Cited by 503 · cited 1×
“A provocative recent study describing the destructive and frequently lethal fungal infection (white nose syndrome) caused by Geomyces destructans in little brown bats (35, 36) when they recover from hibernation also highlights the potential role of metabolism in immune function and of neutrophils in tissue destruction…”
BackgroundJacquelin, B., Mayau, V., Targat, B., Liovat, A.-S., Kunkel, D., Petitjean, G., Dillies, M.-A., Roques, P., Butor, C., Silvestri, G., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40093 · Cited by 481 · cited 1×
“In contrast, in pathogenic models of SIV (rhesus macaques), there is an analogous IFN-induced response during acute infection that persists throughout the chronic phase of infection (103, 104).”
BackgroundAbortive HIV Infection Mediates CD4 T Cell Depletion and Inflammation in Human Lymphoid Tissue
Doitsh, G., Cavrois, M., Lassen, K. G., Zepeda, O., Yang, Z., Santiago, M. L., Hebbeler, A. M., & Greene, W. C. (2010) · Cell · doi:10.1016/j.cell.2010.11.001 · Cited by 452
Projected life expectancy of people with HIV according to timing of diagnosis
Nakagawa, F., Lodwick, R. K., Smith, C. J., Smith, R., Cambiano, V., Lundgren, J. D., Delpech, V., & Phillips, A. N. (2012) · AIDS · doi:10.1097/qad.0b013e32834dcec9 · Cited by 443 · cited 1×
“The success of ART has been such that an HIV+ person who is diagnosed at age 30 and starts therapy when his CD4+ first falls below 500 cells/μL can now be expected to live to age 75 (3).”
BackgroundExpansion of HIV-specific T follicular helper cells in chronic HIV infection
Lindqvist, M., van Lunzen, J., Soghoian, D. Z., Kuhl, B. D., Ranasinghe, S., Kranias, G., Flanders, M. D., Cutler, S., Yudanin, N., Muller, M. I., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64314 · Cited by 418 · cited 1×
“T-follicular helper (Tfh) cells, which nearly exclusively reside in LT and specialize in providing B-cell help for antibody production, appear to be significantly expanded (approximately 10-fold) in the LT of HIVinfected individuals, perhaps driving the hypergammaglobulinemia, increased IL-6, and generalized immune ac…”
BackgroundMoore, R. D., & Keruly, J. C. (2007) · Clinical Infectious Diseases · doi:10.1086/510746 · Cited by 415 · cited 1×
“Although the definition of incomplete CD4 T-cell recovery or immunologic non-response may vary, it is estimated that half of ART-treated patients may fail to reconstitute their CD4 T-cell counts to levels above 500 cells/ll, and up to 16% may not achieve a CD4 T-cell count greater than 200 cells/ll, even with long-ter…”
BackgroundBosinger, S. E., Li, Q., Gordon, S. N., Klatt, N. R., Duan, L., Xu, L., Francella, N., Sidahmed, A., Smith, A. J., Cramer, E. M., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40115 · Cited by 409 · cited 1×
“In contrast, in pathogenic models of SIV (rhesus macaques), there is an analogous IFN-induced response during acute infection that persists throughout the chronic phase of infection (103, 104).”
BackgroundKaufmann, G. R. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.18.2187 · Cited by 409 · cited 1×
“Although the definition of incomplete CD4 T-cell recovery or immunologic non-response may vary, it is estimated that half of ART-treated patients may fail to reconstitute their CD4 T-cell counts to levels above 500 cells/ll, and up to 16% may not achieve a CD4 T-cell count greater than 200 cells/ll, even with long-ter…”
BackgroundFavre, D., Lederer, S., Kanwar, B., Ma, Z.-M., Proll, S., Kasakow, Z., Mold, J., Swainson, L., Barbour, J. D., Baskin, C. R., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000295 · Cited by 405 · cited 1×
“One explanation is that plasmacytoid dendritic cells (pDCs) that have been exposed to and stimulated by HIV secrete high levels of IFNa that appear to promote the differentiation of naive T cells preferentially into Tregs (95), suppressing T-cell effector functions and perhaps leading to the preferential loss of Th17…”
BackgroundKovacs, J. A., Vogel, S., Albert, J. M., Falloon, J., Davey, R. T., Walker, R. E., Polis, M. A., Spooner, K., Metcalf, J. A., Baseler, M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610313351803 · Cited by 402 · cited 1×
“IL-2, an important homeostatic cytokine, led to substantial CD4 T-cell expansions in peripheral blood (116, 117), but in randomized clinical trials combining IL-2 therapy with ART showed no clinical benefit in terms of preventing AIDS-defining illnesses (118).”
Microbial translocation, immune activation, and HIV disease
Klatt, N. R., Funderburg, N. T., & Brenchley, J. M. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2012.09.001 · Cited by 390 · cited 2×
“It has been proposed that microbial translocation (MT) across this damaged mucosa and defective clearance leads to persistent innate system and T-cell activation (81, 82).”
BackgroundReduction of HIV-1 RNA Levels with Therapy to Suppress Herpes Simplex Virus
Nagot, N., Ouédraogo, A., Foulongne, V., Konaté, I., Weiss, H. A., Vergne, L., Defer, M.-C., Djagbaré, D., Sanon, A., Andonaba, J.-B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062607 · Cited by 389 · cited 1×
“Randomized studies of anti-HSV therapy have shown reductions in HIV viral load by approximately half a log (79) and increases in CD4 T-cell counts (80) in ART-naive patients, but it remains unclear if HSV remains a significant contributor to immune activation in ART-treated HIV patients.”
BackgroundMandl, J. N., Barry, A. P., Vanderford, T. H., Kozyr, N., Chavan, R., Klucking, S., Barrat, F. J., Coffman, R. L., Staprans, S. I., & Feinberg, M. B. (2008) · Nature Medicine · doi:10.1038/nm.1871 · Cited by 383 · cited 1×
“In non-pathogenic SIV infection models (sooty mangabeys), there is an initial type I IFN response spike during acute infection that is attenuated during chronic infection (101, 102).”
BackgroundEnhanced T cell recovery in HIV-1–infected adults through IL-7 treatment
Levy, Y., Lacabaratz, C., Weiss, L., Viard, J.-P., Goujard, C., Lelièvre, J.-D., Boué, F., Molina, J.-M., Rouzioux, C., Avettand-Fénoêl, V., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38052 · Cited by 381 · cited 1×
“An alternative candidate common c chain cytokine, IL-7, which prevents apoptosis of T cells and is required for naive T-cell survival in vivo, has been shown to be well tolerated (119) and to increase CD4 T-cell counts in treated HIV patients (120).”
BackgroundInterleukin-2 Therapy in Patients with HIV Infection
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903175 · Cited by 381 · cited 1×
“IL-2, an important homeostatic cytokine, led to substantial CD4 T-cell expansions in peripheral blood (116, 117), but in randomized clinical trials combining IL-2 therapy with ART showed no clinical benefit in terms of preventing AIDS-defining illnesses (118).”
Enhanced CD4+ T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy
Le, T., Wright, E. J., Smith, D. M., He, W., Catano, G., Okulicz, J. F., Young, J. A., Clark, R. A., Richman, D. D., Little, S. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1110187 · Cited by 355 · cited 1×
“Finally, a recent cohort study found that within the first 4 months of HIV infection, there is a narrow ‘restorative time window’ in which the immune system equilibrates after the initial CD4 T-cell losses and thus is poised for recovery, and they observed that starting ART during this period augmented both the rate a…”
MethodRatnam, I., Chiu, C., Kandala, N. B., & Easterbrook, P. J. (2006) · Clinical Infectious Diseases · doi:10.1086/499356 · Cited by 355
Hunt, P. W., Martin, J. N., Sinclair, E., Epling, L., Teague, J., Jacobson, M. A., Tracy, R. P., Corey, L., & Deeks, S. G. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir060 · Cited by 344 · cited 1×
“Administration of antiCMV therapy in HIV-infected patients, on ART for more than 6 months without significant immune reconstitution (CD4 <350 cells/ll) and without CMV end organ disease, was found to reduce some markers of CD8 T-cell activation, but did not increase CD4 T-cell counts (78).”
BackgroundIL-7 administration drives T cell–cycle entry and expansion in HIV-1 infection
Sereti, I., Dunham, R. M., Spritzler, J., Aga, E., Proschan, M. A., Medvik, K., Battaglia, C. A., Landay, A. L., Pahwa, S., Fischl, M. A., et al. (2009) · Blood · doi:10.1182/blood-2008-10-186601 · Cited by 342 · cited 1×
“An alternative candidate common c chain cytokine, IL-7, which prevents apoptosis of T cells and is required for naive T-cell survival in vivo, has been shown to be well tolerated (119) and to increase CD4 T-cell counts in treated HIV patients (120).”
BackgroundSelf-citationHIV-infected T cells are migratory vehicles for viral dissemination
Murooka, T. T., Deruaz, M., Marangoni, F., Vrbanac, V. D., Seung, E., von Andrian, U. H., Tager, A. M., Luster, A. D., & Mempel, T. R. (2012) · Nature · doi:10.1038/nature11398 · Cited by 322 · cited 1×
“New data from Thorston Mempel’s laboratory (89) have shown how infected T cells can migrate quickly in LNs, forming complex tethering interactions with multiple uninfected cells, enabling viral dissemination while remaining sequestered in lymph nodes.”
BackgroundFranceschini, D., Paroli, M., Francavilla, V., Videtta, M., Morrone, S., Labbadia, G., Cerino, A., Mondelli, M. U., & Barnaba, V. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36604 · Cited by 318
CD4 T follicular helper cell dynamics during SIV infection
Petrovas, C., Yamamoto, T., Gerner, M. Y., Boswell, K. L., Wloka, K., Smith, E. C., Ambrozak, D. R., Sandler, N. G., Timmer, K. J., Sun, X., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63039 · Cited by 317 · cited 1×
“T-follicular helper (Tfh) cells, which nearly exclusively reside in LT and specialize in providing B-cell help for antibody production, appear to be significantly expanded (approximately 10-fold) in the LT of HIVinfected individuals, perhaps driving the hypergammaglobulinemia, increased IL-6, and generalized immune ac…”
BackgroundAnanworanich, J., Schuetz, A., Vandergeeten, C., Sereti, I., de Souza, M., Rerknimitr, R., Dewar, R., Marovich, M., van Griensven, F., Sekaly, R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033948 · Cited by 314 · cited 1×
“A trial of increased intensity ART (a regimen of tenofovir, emtricitabine, efavirenz, raltegravir, and maraviroc) started in early acute HIV infection (Fiebig stages I-III) found that this intensive early therapy was able to limit reservoir size at 24 weeks and partially restore gut mucosal T-cell counts (112).”
BackgroundSelf-citationKaufmann, G. R., Furrer, H., Ledergerber, B., Perrin, L., Opravil, M., Vernazza, P., Cavassini, M., Bernasconi, E., Rickenbach, M., Hirschel, B., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/431484 · Cited by 313 · cited 1×
“Some of the risk factors for a limited CD4 T-cell recovery include older age (40), lower CD4 T-cell nadir prior to ART (41), and active co-infection, most notably with hepatitis C virus (42, 43), but the strongest predictor remains a lower nadir CD4 T-cell count before ART initiation.”
BackgroundCumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections
Zeng, M., Smith, A. J., Wietgrefe, S. W., Southern, P. J., Schacker, T. W., Reilly, C. S., Estes, J. D., Burton, G. F., Silvestri, G., Lifson, J. D., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45157 · Cited by 309 · cited 1×
“Further research into this area has revealed that the inflammation and activation of transforming growth factor b (TGFb) pathway found in HIV-infected patients leads to fibrosis that disrupts the tissue architecture and impedes naive T-cell access to survival cytokines including IL-7, resulting in their apoptotic depl…”
BackgroundHIV Infection of Naturally Occurring and Genetically Reprogrammed Human Regulatory T-cells
Oswald-Richter, K., Grill, S. M., Shariat, N., Leelawong, M., Sundrud, M. S., Haas, D. W., & Unutmaz, D. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020198 · Cited by 301 · cited 1×
“Tregs, the circulating subset of CD4 T cells with suppressive activity, are relatively increased in frequency in PB, but overall, their numbers are depleted, and it remains unclear whether this reflects redistribution between PB and LT (91, 92), preferential infection by HIV (93), or the inherent higher rates of turno…”
BackgroundImmune Reconstitution Inflammatory Syndrome Associated With Kaposi's Sarcoma
Bower, M., Nelson, M. R., Young, A. M., Thirlwell, C., Newsom‐Davis, T., Mandalia, S., Dhillon, T., Holmes, P., Gazzard, B., & Stebbing, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.597 · Cited by 287
Gordon, S. N., Klatt, N. R., Bosinger, S. E., Brenchley, J. M., Milush, J. M., Engram, J. C., Dunham, R. M., Paiardini, M., Klucking, S., Danesh, A., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.3026 · Cited by 286 · cited 1×
“Elite controllers appear to have intact mucosal T cells (50), despite recent evidence of increased inflammatory biomarkers (sCD163, LPS) and possible cardiovascular disease, suggesting that the mucosal T cells are not the necessary injury that connects systemic inflammation with HIV, as was also highlighted in non-pat…”
BackgroundFunderburg, N. T., Mayne, E., Sieg, S. F., Asaad, R., Jiang, W., Kalinowska, M., Luciano, A. A., Stevens, W., Rodriguez, B., Brenchley, J. M., et al. (2010) · Blood · doi:10.1182/blood-2009-03-210179 · Cited by 285 · cited 1×
“Further studies have shown that cardiovascular disease risk is strongly associated with increased activation of monocytes (106, 107) and plasma levels of sCD14 (108, 109) as well as increased proportions of monocytes and platelets expressing cell-surface tissue factor (TF).”
BackgroundCollagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis
Schacker, T. W., Nguyen, P. L., Beilman, G. J., Wolinsky, S., Larson, M., Reilly, C., & Haase, A. T. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216413 · Cited by 283 · cited 2×
“In 2002, Ashley Haase’s group (46) reported a strong negative correlation between both CD4 T-cell counts and the degree of peripheral CD4 T-cell reconstitution on ART with the extent of collagen deposition in the paracortical T-cell zone in lymphoid tissue (LT) of individuals with chronic HIV infection.”
BackgroundMurdoch, D. M., Venter, W. D., Feldman, C., & Van Rie, A. (2008) · AIDS · doi:10.1097/qad.0b013e3282f4a607 · Cited by 280
Boulware, D. R., Meya, D. B., Bergemann, T. L., Wiesner, D. L., Rhein, J., Musubire, A., Lee, S. J., Kambugu, A., Janoff, E. N., & Bohjanen, P. R. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000384 · Cited by 279 · cited 1×
“This last point appears to be in agreement with human data from several groups that are now unraveling the role of the innate system in the pathogenesis of IRIS with the most striking observations in TB and cryptococcal IRIS (32).”
ResultHarris, L. D., Tabb, B., Sodora, D. L., Paiardini, M., Klatt, N. R., Douek, D. C., Silvestri, G., Müller-Trutwin, M. C., Vasile-Pandrea, I., Apetrei, C., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02612-09 · Cited by 251 · cited 1×
“In non-pathogenic SIV infection models (sooty mangabeys), there is an initial type I IFN response spike during acute infection that is attenuated during chronic infection (101, 102).”
BackgroundFrench, M. A., King, M. S., Tschampa, J. M., da Silva, B. A., & Landay, A. L. (2009) · The Journal of Infectious Diseases · doi:10.1086/605890 · Cited by 242
Lévy, Y., Sereti, I., Tambussi, G., Routy, J. P., Lelièvre, J. D., Delfraissy, J. F., Molina, J. M., Fischl, M., Goujard, C., Rodriguez, B., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis383 · Cited by 240 · cited 1×
“These T cells remain capable of responding to antigenic stimuli and producing cytokines after polyclonal and specific antigenic stimulation, and the repopulation appears to extend from thymus to PB, LT, and effector sites (121, 122).”
BackgroundSelf-citationRobbins, G. K., Spritzler, J. G., Chan, E. S., Asmuth, D. M., Gandhi, R. T., Rodriguez, B. A., Skowron, G., Skolnik, P. R., Shafer, R. W., Pollard, R. B., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/595888 · Cited by 231
Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers
Pereyra, F., Lo, J., Triant, V. A., Wei, J., Buzon, M. J., Fitch, K. V., Hwang, J., Campbell, J. H., Burdo, T. H., Williams, K. C., et al. (2012) · AIDS · doi:10.1097/qad.0b013e32835a9950 · Cited by 223 · cited 1×
“These persons also have elevated levels of inflammatory biomarkers, immune activation, and non-AIDS events, including atherosclerosis, in the absence of uncontrolled viremia or ART (72, 73), suggesting that the low (below detection by routine assays) HIV viremia may be playing a role in chronic inflammation in HIV.”
BackgroundValdez, H., Connick, E., Smith, K. Y., Lederman, M. M., Bosch, R. J., Kim, R. S., St. Clair, M., Kuritzkes, D. R., Kessler, H., Fox, L., et al. (2002) · AIDS · doi:10.1097/00002030-200209270-00002 · Cited by 211
Chronic innate immune activation as a cause of HIV-1 immunopathogenesis
Boasso, A., & Shearer, G. M. (2008) · Clinical Immunology · doi:10.1016/j.clim.2007.08.015 · Cited by 206
Ford, E. S., Greenwald, J. H., Richterman, A. G., Rupert, A., Dutcher, L., Badralmaa, Y., Natarajan, V., Rehm, C., Hadigan, C., & Sereti, I. (2010) · AIDS · doi:10.1097/qad.0b013e32833ad914 · Cited by 195 · cited 1×
“In studies by our group, D-dimer and soluble TF (sTF), but not markers of T-cell activation, were associated with development of cardiovascular disease and venous thromboembolic disease in long-term treated HIV infection (65, 111) and with biomarkers of coagulation in elite controllers (unpublished data).”
BackgroundSelf-citationAntonelli, L. R. V., Mahnke, Y., Hodge, J. N., Porter, B. O., Barber, D. L., DerSimonian, R., Greenwald, J. H., Roby, G., Mican, J., Sher, A., et al. (2010) · Blood · doi:10.1182/blood-2010-05-285080 · Cited by 181 · cited 2×
“This was refuted by the fact that most IRIS patients have evidence of expanding effector memory T cells that express high levels of activation markers (PD-1 and Ki67) with a T-helper 1 (Th1) predilection (21), suggesting antigen-driven expansion and activation, rather than a predominance of homeostatic proliferation.”
ResultSelf-citationImmune reconstitution inflammatory syndrome: the trouble with immunity when you had none
Barber, D. L., Andrade, B. B., Sereti, I., & Sher, A. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2712 · Cited by 169 · cited 2×
“Based on the existing data, our hypothesis is that IRIS results from the uncoupling of the innate and adaptive immune response during microbial infection: the cells of the innate immune system are primed and activated when antigen-specific CD4 T cells are absent or inactive, and when these antigen-specific cells recov…”
BackgroundSelf-citationKaufmann, G. R., Bloch, M., Finlayson, R., Zaunders, J., Smith, D., & Cooper, D. A. (2002) · AIDS · doi:10.1097/00002030-200202150-00007 · Cited by 169 · cited 1×
“Some of the risk factors for a limited CD4 T-cell recovery include older age (40), lower CD4 T-cell nadir prior to ART (41), and active co-infection, most notably with hepatitis C virus (42, 43), but the strongest predictor remains a lower nadir CD4 T-cell count before ART initiation.”
BackgroundCalabrese, L. H., Kirchner, E., & Shrestha, R. (2005) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2005.03.007 · Cited by 167
Mavigner, M., Cazabat, M., Dubois, M., L’Faqihi, F.-E., Requena, M., Pasquier, C., Klopp, P., Amar, J., Alric, L., Barange, K., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59011 · Cited by 166 · cited 1×
“Recent data suggest a possible defect in gut homing that may be contributing to this ineffective repopulation (84), highlighting how studies ought to extend beyond peripheral blood to assess tissue-homing receptors and cell trafficking in conditions of perturbed homeostasis (85).”
BackgroundBaker, J. V., Neuhaus, J., Duprez, D., Kuller, L. H., Tracy, R., Belloso, W. H., De Wit, S., Drummond, F., Lane, H. C., Ledergerber, B., et al. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181f7f61a · Cited by 162
Nyirenda, M. H., Sanvito, L., Darlington, P. J., O’Brien, K., Zhang, G.-X., Constantinescu, C. S., Bar-Or, A., & Gran, B. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003715 · Cited by 160
Hearps, A. C., Maisa, A., Cheng, W.-J., Angelovich, T. A., Lichtfuss, G. F., Palmer, C. S., Landay, A. L., Jaworowski, A., & Crowe, S. M. (2012) · AIDS · doi:10.1097/qad.0b013e328351f756 · Cited by 159
Mayne, E. S., Funderburg, N., Sieg, S. F., Asaad, R. J., Kalinowska, M., Rodriguez, B. A., Schmaier, A. H., Stevens, W. S., & Lederman, M. M. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182439355 · Cited by 156 · cited 1×
“Further studies have shown that cardiovascular disease risk is strongly associated with increased activation of monocytes (106, 107) and plasma levels of sCD14 (108, 109) as well as increased proportions of monocytes and platelets expressing cell-surface tissue factor (TF).”
BackgroundCatálfamo, M., Mascio, M. D., Hu, Z., Srinivasula, S., Thaker, V., Adelsberger, J. W., Rupert, A. W., Baseler, M., Tagaya, Y., Roby, G. A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810032105 · Cited by 154 · cited 1×
“T cells of HIV-infected patients are also less responsive to IL-7, a necessary survival signal sustaining naive CD4 T-cell populations, than are uninfected controls, and in ART-treated patients, IL-7 responsiveness correlates strongly with the extent of CD4 T-cell reconstitution (52, 53).”
BackgroundTh17 cell dynamics in HIV infection
Klatt, N. R., & Brenchley, J. M. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3283364846 · Cited by 151 · cited 2×
“Th17 cells, critical in mounting an inflammatory defense against bacterial and fungal microbes at mucosal surfaces, are preferentially lost from GALT in HIV infection, but not from PB (90).”
BackgroundCollagen Deposition Limits Immune Reconstitution in the Gut
Estes, J. D., Baker, J. V., Brenchley, J. M., Khoruts, A., Barthold, J. L., Bantle, A., Reilly, C., Beilman, G. J., George, M. E., Douek, D. C., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/590112 · Cited by 148 · cited 1×
“Fibrosis in other sites, including mucosal effector sites, has also been shown in HIV infection, and this may correlate with the extent of immune recovery of these sites after ART (57, 58).”
BackgroundO’Brien, M. P., Manches, O., Sabado, R. L., Baranda, S. J., Wang, Y., Marie, I., Rolnitzky, L. M., Markowitz, M. H., Margolis, D. M., Levy, D. E., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44960 · Cited by 146 · cited 1×
“After initiation of ART, pDC function remains impaired, with some evidence of enhanced type I IFN production in response to HIV and partial maturation to a phenotype of inflammatory cytokine production that can support effective T-cell responses (105).”
BackgroundAnthony, K. B., Yoder, C. P., Metcalf, J. A., DerSimonian, R., Orenstein, J. M., Stevens, R. A., Falloon, J., Polis, M. A., Lane, H. C., & Sereti, I. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200306010-00002 · Cited by 142
Self-citationMeteyer, C. U., Barber, D. L., & Mandl, J. N. (2012) · Virulence · doi:10.4161/viru.22330 · Cited by 139 · cited 1×
“A provocative recent study describing the destructive and frequently lethal fungal infection (white nose syndrome) caused by Geomyces destructans in little brown bats (35, 36) when they recover from hibernation also highlights the potential role of metabolism in immune function and of neutrophils in tissue destruction…”
BackgroundLlibre, J. M., Buzón, M. J., Massanella, M., Esteve, A., Dahl, V., Puertas, M. C., Domingo, P., Gatell, J. M., Larrouse, M., Gutiérrez, M. D. M., et al. (2011) · Antiviral Therapy · doi:10.3851/imp1917 · Cited by 134 · cited 2×
“Intensification with the integrase inhibitor raltegravir has shown transient decreases in T-cell activation (70) and alterations in RANTES and MIP-1 b expression (127), but, again, without any associated improvements in CD4 T-cell counts or other long-term outcomes.”
BackgroundResultNaidoo, K., Yende‐Zuma, N., Padayatchi, N., Naidoo, K., Jithoo, N., Nair, G., Bamber, S., Gengiah, S., El‐Sadr, W., FRIEDLAND, G. H., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-5-201209040-00004 · Cited by 129 · cited 4×
“New guidelines recommending early initiation of ART in patients with tuberculosis (TB) and HIV co-infection are expected to further increase the incidence and burden of TB-IRIS (14).”
BackgroundInfluentialEvering, T. H., Mehandru, S., Racz, P., Tenner-Racz, K., Poles, M. A., Figueroa, A., Mohri, H., & Markowitz, M. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002506 · Cited by 128 · cited 1×
“Another study showed that the initiation of ART in early HIV infection was associated with no measurable viral evolution in the GALT, suggesting that early therapy may effectively inhibit viral replication in this compartment (113).”
BackgroundLymphoid tissue structure and HIV-1 infection: life or death for T cells
Zeng, M., Haase, A. T., & Schacker, T. W. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.04.002 · Cited by 128 · cited 2×
“HIV infection furthermore reduces the pool of naive CD4 T cells through continuous depletion of naive T cells, both by maturing into memory T cells and because of decreased survival (47).”
BackgroundParrinello, C. M., Sinclair, E., Landay, A. L., Lurain, N., Sharrett, A. R., Gange, S. J., Xue, X., Hunt, P. W., Deeks, S. G., Hodis, H. N., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis276 · Cited by 126 · cited 1×
“More specifically, CMV-specific T cells have been implicated in atherosclerosis, which has a well-studied component of innate immune activation (76, 77).”
BackgroundHIV-1 Continues To Replicate and Evolve in Patients with Natural Control of HIV Infection
Mens, H., Kearney, M. F., Wiegand, A. P., Shao, W., Schønning, K., Gerstoft, J., Obel, N., Maldarelli, F. M., Mellors, J. W., Benfield, T., et al. (2010) · Journal of Virology · doi:10.1128/jvi.00387-10 · Cited by 120 · cited 1×
“Although their viral loads are below the limit of detection in conventional assays (<50 copies/ml), they also frequently have measurable low level viremia, ongoing viral replication, and evolution of their viral reservoir (71).”
BackgroundGuihot, A., Bourgarit, A., Carcelain, G., & Autran, B. (2011) · Trends in Immunology · doi:10.1016/j.it.2010.12.002 · Cited by 120 · cited 2×
“Antigen-experienced CD4 T cells, particularly those in the central memory compartment, appear to be preferentially lost in HIV infection, with newer evidence suggesting that antigen specificity may influence their susceptibility based on their degree of Th17 cytokine expression (44, 45).”
BackgroundTan, R., Westfall, A. O., Willig, J. H., Mugavero, M. J., Saag, M. S., Kaslow, R. A., & Kempf, M.-C. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31816856c5 · Cited by 114 · cited 1×
“These individuals with lack of immunologic recovery, despite suppression of viral replication, are at higher risk for clinical events, including death, AIDS-defining events, malignancies, cardiovascular events, and severe infections compared with those with more substantial CD4 T-cell increases (38, 39).”
Gandhi, R. T., Coombs, R. W., Chan, E. S., Bosch, R. J., Zheng, L., Margolis, D. M., Read, S., Kallungal, B., Chang, M., Goecker, E. A., et al. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31823fd1f2 · Cited by 107 · cited 1×
“However, intensification of ART with the addition of alternative classes of medications has shown mostly negative results in further suppressing the viremia or T-cell activation (68, 69), with one study showing a transient decrease in markers of HIV integration with an associated decrease in T-cell activation markers…”
ResultCollagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis
Schacker, T. W., Nguyen, P. L., Beilman, G. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16413 · Cited by 106
Ciccone, E. J., Greenwald, J. H., Lee, P. I., Biancotto, A., Read, S. W., Yao, M., Hodge, J. N., Thompson, W. L., Kovacs, S. B., Chairez, C. L., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02643-10 · Cited by 103 · cited 2×
“Elite controllers appear to have intact mucosal T cells (50), despite recent evidence of increased inflammatory biomarkers (sCD163, LPS) and possible cardiovascular disease, suggesting that the mucosal T cells are not the necessary injury that connects systemic inflammation with HIV, as was also highlighted in non-pat…”
BackgroundSelf-citationGutiérrez, C., Díaz, L., Vallejo, A., Hernández‐Novoa, B., Abad-Fernández, M., Madrid, N., Dahl, V., Rubio, R., Moreno, A. M., Dronda, F., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027864 · Cited by 101 · cited 1×
“Initial studies have given inconclusive results: intensification with MVC did not increase CD4 T-cell counts of HIV patients with poor immunologic response, but markers of T-cell activation, cell cycling, and apoptosis decreased during MVC therapy (125, 126).”
ResultImbalance in distribution of functional autologous regulatory T cells in rheumatoid arthritis
Behrens, F., Himsel, A., Rehart, S., Stanczyk, J., Beutel, B., Zimmermann, S. Y., Koehl, U., Möller, B., Gay, S., Kaltwasser, J., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.068320 · Cited by 97
Mahnke, Y. D., Greenwald, J. H., DerSimonian, R., Roby, G. A., Antonelli, L. R. D. V., Sher, A., Roederer, M., & Sereti, I. (2012) · Blood · doi:10.1182/blood-2011-09-380840 · Cited by 96 · cited 1×
“In support of this, when antigen-specific responses were studied, CD4 T cells from patients with IRIS events were more likely to have robust and polyfunctional [producing an array of cytokines, interleukin-2 (IL-2), interferon c (IFNc), and tumor necrosis factor (TNF)] responses targeting specifically the underlying o…”
BackgroundSelf-citationCimbro, R., Vassena, L., Arthos, J., Cicala, C., Kehrl, J. H., Park, C., Sereti, I., Lederman, M. M., Fauci, A. S., & Lusso, P. (2012) · Blood · doi:10.1182/blood-2012-06-434779 · Cited by 94 · cited 1×
“These T cells remain capable of responding to antigenic stimuli and producing cytokines after polyclonal and specific antigenic stimulation, and the repopulation appears to extend from thymus to PB, LT, and effector sites (121, 122).”
BackgroundSelf-citationLapadula, G., Cozzi‐Lepri, A., Marchetti, G. C., Antinori, A., Chiodera, A., Nicastri, E., Parruti, G., Galli, M., Gori, A., & Monforte, A. D. (2012) · AIDS · doi:10.1097/qad.0b013e32835cb747 · Cited by 93 · cited 1×
“These individuals with lack of immunologic recovery, despite suppression of viral replication, are at higher risk for clinical events, including death, AIDS-defining events, malignancies, cardiovascular events, and severe infections compared with those with more substantial CD4 T-cell increases (38, 39).”
Biomarkers in immune reconstitution inflammatory syndrome: signals from pathogenesis
Sereti, I., Rodger, A., & French, M. A. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833ed774 · Cited by 93
Self-citationSacré, K., Hunt, P. W., Hsue, P. Y., Maidji, E., Martin, J. N., Deeks, S. G., Autran, B., & McCune, J. M. (2012) · AIDS · doi:10.1097/qad.0b013e328351f780 · Cited by 88 · cited 1×
“More specifically, CMV-specific T cells have been implicated in atherosclerosis, which has a well-studied component of innate immune activation (76, 77).”
BackgroundMusselwhite, L. W., Sheikh, V., Norton, T. D., Rupert, A. W., Porter, B. O., Penzak, S. R., Skinner, J., Mican, J. M., Hadigan, C. M., & Sereti, I. (2011) · AIDS · doi:10.1097/qad.0b013e3283453fcb · Cited by 88 · cited 1×
“In studies by our group, D-dimer and soluble TF (sTF) but not markers of T-cell activation were associated with development of cardiovascular disease and venous thromboembolic disease in long-term treated HIV infection (65, 111) and with biomarkers of coagulation in elite controllers (unpublished data).”
BackgroundSelf-citationBiomarkers of HIV Immune Reconstitution Inflammatory Syndrome
Bonham, S., Meya, D. B., Bohjanen, P. R., & Boulware, D. R. (2008) · Biomarkers in Medicine · doi:10.2217/17520363.2.4.349 · Cited by 88
Camargo, J. F., Quinones, M. P., Mummidi, S., Srinivas, S., Gaitan, A. A., Begum, K., Jimenez, F., VanCompernolle, S., Unutmaz, D., Ahuja, S. S., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.171 · Cited by 86 · cited 1×
“It also prevents receptor binding by CCL3 and CCL4 (known as monocyte inflammatory proteins 1 a and b, MIP-1 1 a and b), members of the b chemokine family that when bound to the CCR5 receptor can trigger Tcell activation and proliferation (123).”
BackgroundAssociation between Use of HMG CoA Reductase Inhibitors and Mortality in HIV-Infected Patients
Moore, R. D., Bartlett, J. G., & Gallant, J. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021843 · Cited by 83 · cited 1×
“Other immunomodulating drugs, particularly those with anti-inflammatory activity including methotrexate, shown to reduce cardiovascular events in patients with rheumatoid arthritis (130), and statins (131) continue to be investigated, and as we have shown, studies should predominantly focus on targets related to innat…”
Zeng, M., Paiardini, M., Engram, J. C., Beilman, G. J., Chipman, J. G., Schacker, T. W., Silvestri, G., & Haase, A. T. (2012) · Blood · doi:10.1182/blood-2012-03-418624 · Cited by 80 · cited 1×
“Some experts have hypothesized that inhibitors of the TGFb pathway (47) and medications that might help restore the fibroblastic reticular cell network of LT by activating the lymphotoxin B signaling receptor pathway (129) would be worthy of further investigation.”
BackgroundCiccone, E. J., Read, S., Mannon, P., Yao, M. D., Hodge, J. N., Dewar, R. L., Chairez, C. L., Proschan, M. A., Kovacs, J. A., & Sereti, I. (2009) · Mucosal Immunology · doi:10.1038/mi.2009.129 · Cited by 79 · cited 2×
“Although treatment with ART can produce a remarkable restoration of peripheral CD4 T cells, reduce CD4 T-cell activation, and improve CD4 T-cell populations at effector sites (51), some reports showed that restoration of CD4 T cells in the lamina propria may be incomplete, even after up to 5 years on ART (83).”
BackgroundSelf-citationGeneralized immune activation and innate immune responses in simian immunodeficiency virus infection
Bosinger, S. E., Sodora, D. L., & Silvestri, G. (2011) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3283499cf6 · Cited by 73 · cited 1×
“Studies of DC subsets in non-human primates and SIV models have supported the hypothesis that DC dysfunction, particularly increased IFNa production by pDCs, contributes to HIV pathogenesis and chronic immune activation (100).”
BackgroundTh1-driven immune reconstitution disease in Mycobacterium avium–infected mice
Barber, D. L., Mayer-Barber, K. D., Antonelli, L. R. D. V., Wilson, M. S., White, S., Caspar, P., Hieny, S. E., Sereti, I., & Sher, A. (2010) · Blood · doi:10.1182/blood-2010-05-286336 · Cited by 71 · cited 2×
“Transfer of naive CD4 T cells leads to wasting and death of the lymphopenic but not T-cell-replete MAC-infected mice (16).”
BackgroundSelf-citationManagement of patients with the immune reconstitution inflammatory syndrome
Marais, S., Wilkinson, R. J., Pepper, D. J., & Meintjes, G. (2009) · Current HIV/AIDS Reports · doi:10.1007/s11904-009-0022-z · Cited by 66 · cited 1×
“The mainstay of treatment is currently corticosteroids (15), although targeted immunomodulatory interventions guided by a better comprehension of pathogenesis would be preferable in an already immunocompromised host.”
BackgroundHoenig, M., & Schwarz, K. (2006) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000231907.50290.6f · Cited by 64 · cited 1×
“Based on these observations, it was initially hypothesized that IRIS may represent a break of tolerance phenomenon similar to the autoimmune manifestations in lymphopenic mouse models (20) in which unrestrained lymphopenia-induced proliferation leads to lack of self-recognition and autoimmunity.”
BackgroundPean, P., Nerrienet, E., Madec, Y., Borand, L., Laureillard, D., Fernandez, M., Marcy, O., Sarin, C., Phon, K., Taylor, S., et al. (2012) · Blood · doi:10.1182/blood-2011-09-377523 · Cited by 62 · cited 4×
“New guidelines recommending early initiation of ART in patients with tuberculosis (TB) and HIV co-infection are expected to further increase the incidence and burden of TB-IRIS (14).”
BackgroundInfluentialTabb, B., Morcock, D. R., Trubey, C. M., Quiñones, O. A., Hao, X., Smedley, J. V., MacAllister, R., Piatak, M., Harris, L. D., Paiardini, M., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis643 · Cited by 59 · cited 1×
“Interestingly, blocking the effects of TNFα in acute simian immunodeficiency virus (SIV) infection was shown to prevent fibrosis of LT, without any decrease in T-cell activation or change in CD4+ T-cell counts or SIV viremia (56).”
BackgroundCamargo, J. F., Kulkarni, H. R., Agan, B. K., Gaitán, Á. A., Beachy, L. A., Srinivas, S., He, W., Anderson, S., Marconi, V. C., Dolan, M. J., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/598858 · Cited by 58 · cited 1×
“T cells of HIV-infected patients are also less responsive to IL-7, a necessary survival signal sustaining naive CD4 T-cell populations, than are uninfected controls, and in ART-treated patients, IL-7 responsiveness correlates strongly with the extent of CD4 T-cell reconstitution (52, 53).”
BackgroundGrant, P., Komarow, L., Lederman, M. M., Pahwa, S. G., Zolopa, A. R., Andersen, J., Asmuth, D. M., Devaraj, S., Pollard, R. B., Richterman, A. G., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis604 · Cited by 55
Self-citationHIV-1 infection–induced apoptotic microparticles inhibit human DCs via CD44
Frleta, D., Ochoa, C. E., Kramer, H., Khan, S. A., Stacey, A., Borrow, P., Kessler, B. M., Haynes, B. F., & Bhardwaj, N. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64439 · Cited by 54 · cited 1×
“Recent data showing that apoptotic microparticles in HIV viremic patients may stifle dendritic cell (DC) activity would further support this notion (34), suggesting that decreasing these microparticles with anti-HIV therapy could abruptly reverse the dysfunction of DCs.”
BackgroundHu, H., Nau, M. E., Ehrenberg, P. K., Chenine, A., Macedo, C., Zhou, Y., Daye, Z. J., Wei, Z., Vahey, M., Michael, N. L., et al. (2012) · Blood · doi:10.1182/blood-2012-07-446278 · Cited by 47
Hodge, J. N., Srinivasula, S., Hu, Z., Read, S. W., Porter, B. O., Kim, I., Mican, J. M., Paik, C. H., DeGrange, P., Mascio, M. D., et al. (2011) · Blood · doi:10.1182/blood-2010-12-323600 · Cited by 46 · cited 1×
“In addition, reconstitution in the first 2 years of ART appears to be driven predominantly by T cells expressing the a chain of the IL-7 receptor (CD127) (54).”
BackgroundSelf-citationImmune reconstitution inflammatory syndrome: immune restoration disease 20 years on
French, M. A. (2012) · The Medical Journal of Australia · doi:10.5694/mja12.10089 · Cited by 40
Taiwo, B., Barcena, L., & Tressler, R. (2012) · Current HIV/AIDS Reports · doi:10.1007/s11904-012-0147-3 · Cited by 39 · cited 1×
“Other chronic viral infections, such as herpes simplex virus (HSV) and viral hepatitis that are disproportionately common in HIV-infected patients (74) as well as cytomegalovirus (CMV) with more than 90% of HIV patients seropositive for it (75), may contribute to immune activation.”
BackgroundChege, D., Kovacs, C. M., la Porte, C., Ostrowski, M., Raboud, J., Su, D., Kandel, G. P., Brunetta, J., Kim, C. J., Sheth, P. M., et al. (2011) · AIDS · doi:10.1097/qad.0b013e32834e8955 · Cited by 37 · cited 1×
“However, intensification of ART with the addition of alternative classes of medications has shown mostly negative results in further suppressing the viremia or T-cell activation (68, 69), with one study showing a transient decrease in markers of HIV integration with an associated decrease in Tcell activation markers i…”
Xing, S., Fu, J., Zhang, Z., Gao, Y., Jiao, Y., Kang, F., Zhang, J., Zhou, C., Wu, H., & Wang, F. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181e453b9 · Cited by 35 · cited 1×
“Tregs, the circulating subset of CD4 T cells with suppressive activity, are relatively increased in frequency in PB, but overall, their numbers are depleted, and it remains unclear whether this reflects redistribution between PB and LT (91, 92), preferential infection by HIV (93), or the inherent higher rates of turno…”
BackgroundHayes, T. L., Asmuth, D. M., Critchfield, J. W., Knight, T. H., McLaughlin, B. E., Yotter, T., McConnell, D. H., Garcia, J. C., Pollard, R. B., & Shacklett, B. L. (2012) · AIDS · doi:10.1097/qad.0b013e32835d85b4 · Cited by 31 · cited 1×
“Recent data suggest a possible defect in gut homing that may be contributing to this ineffective repopulation (84), highlighting how studies ought to extend beyond peripheral blood to assess tissue-homing receptors and cell trafficking in conditions of perturbed homeostasis (85).”
BackgroundTadokera, R., Wilkinson, K. A., Meintjes, G., Skolimowska, K. H., Matthews, K., Seldon, R., Rangaka, M. X., Maartens, G., & Wilkinson, R. J. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit002 · Cited by 31
Yin, L., Kou, Z. C., Rodriguez, C. A., Hou, W., Goodenow, M. M., & Sleasman, J. W. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00074-09 · Cited by 24 · cited 1×
“With the initiation of ART, the accelerated differentiation of naive CD4 T cells into memory cells is slowed (1, 48), leading to replenishment of the naive subset (44) and a restoration of the CD4 TCR diversity (49).”
BackgroundLichtenstein, K. A., Armon, C., Nagabhushanam, V., Efaw, B. J., Frazer‐Abel, A. A., Hiserote, M., & Alam, R. (2012) · Antiviral Therapy · doi:10.3851/imp2350 · Cited by 19 · cited 1×
“Intensification with the integrase inhibitor raltegravir has shown transient decreases in T-cell activation (70) and alterations in RANTES and MIP-1 b expression (127), but, again, without any associated improvements in CD4 T-cell counts or other long-term outcomes.”
BackgroundPiwowar‐Manning, E., Henderson, T. A., Brisbin, L., & Jackson, J. B. (2003) · American Journal of Clinical Pathology · doi:10.1309/trrqfwm9le9h427m · Cited by 10 · cited 1×
“Ultra-sensitive assays detecting levels of viremia between 1 and 49 copies/ml have repeatedly shown that lower levels of HIV can still be identified in patients on ART (66, 67).”
BackgroundHIV infection, lymphoid fibrosis, and disease
Deeks, S. G. (2012) · Blood · doi:10.1182/blood-2012-06-433987 · Cited by 9 · cited 1×
“In an attempt to target the lymphoid fibrosis associated with chronic treated HIV infection, clinical trials are underway to evaluate medications that inhibit fibrosis, including angiotensin receptor blockers and angiotensin-converting enzyme inhibitors (128).”
BackgroundRoxby, A. C., Drake, A. L., Ongecha-Owuor, F., Kiarie, J. N., Richardson, B. A., Matemo, D. N., Overbaugh, J., Emery, S., John-Stewart, G. C., Wald, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038622 · Cited by 9 · cited 1×
“Randomized studies of anti-HSV therapy have shown reductions in HIV viral load by approximately half a log (79) and increases in CD4 T-cell counts (80) in ART-naive patients, but it remains unclear if HSV remains a significant contributor to immune activation in ART-treated HIV patients.”
BackgroundHIV Infection and the Gut: Scarred for Life?
Read, S. W., & Sereti, I. (2008) · The Journal of Infectious Diseases · doi:10.1086/590113 · Cited by 7 · cited 1×
“Fibrosis in other sites, including mucosal effector sites, has also been shown in HIV infection, and this may correlate with the extent of immune recovery of these sites after ART (57, 58).”
BackgroundSelf-citationIRIS: the unfortunate rainbow of HIV
Chahroudi, A., & Silvestri, G. (2012) · Blood · doi:10.1182/blood-2012-01-403683 · Cited by 4 · cited 1×
“In support of this, when antigen-specific responses were studied, CD4 T cells from patients with IRIS events were more likely to have robust and polyfunctional [producing an array of cytokines, interleukin-2 (IL-2), interferon c (IFNc), and tumor necrosis factor (TNF)] responses targeting specifically the underlying o…”
Background
Cited by
(2020) · doi:10.1016/s2214-109x(20)30264-3 · Cited by 1,190
Clonally expanded CD4 + T cells can produce infectious HIV-1 in vivo
Simonetti, F. R., Sobolewski, M. D., Fyne, E., Shao, W., Spindler, J., Hattori, J., Anderson, E. M., Watters, S. A., Hill, S., Wu, X., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522675113 · Cited by 372
Vujkovic-Cvijin, I., Sortino, O., Verheij, E., Sklar, J., Wit, F. W., Kootstra, N. A., Sellers, B., Brenchley, J. M., Ananworanich, J., Loeff, M. S. V. D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16222-8 · Cited by 196
“Comorbidities objectively assessed during each study visit were: (1) chronic obstructive pulmonary disease (COPD) (GOLD 2 or more by spirometry); (2) advanced liver fibrosis (FIB-4 ≥ 3.”
MethodSelf-citationSiderophores: More than Stealing Iron
Behnsen, J., & Raffatellu, M. (2016) · mBio · doi:10.1128/mbio.01906-16 · Cited by 79
Metadata
- Authors
- Wilson, E. M. P., & Sereti, I.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2013-06-16
- Volume
- 254
- Issue
- 1
- Pages
- 343-354
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W2087450881
- Cited by
- 167
- References
- 123
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.